Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Bristol-Myers Squibb and Gilead Sciences filed for Food and Drug Administration approval in late April of their three-drug combination pill that's taken just once daily. The pill contains a full day's doses of Sustiva, Viread, and Emtriva. A decision by the FDA is expected before the end of the year. A study in the Journal of Antimicrobial Chemotherapyidentifies the causes of poor interaction between Videx and Viread that leads to a drop in CD4-cell levels. Combining the drugs interferes with the intercellular activation pathways of the medications and blocks a key enzyme in the body. A 48-week study of Lexiva and Kaletra show the two protease inhibitors are comparable in their ability to reduce blood-based HIV levels. The study shows 73% of people taking Norvir-boosted Lexiva suppressed viral loads to undetectable levels, compared to 71% of those taking Kaletra, which already contains a booster dose of Norvir. Almost two thirds of highly drug-resistant HIVers who switched from multidrug therapy to taking only the protease inhibitor Kaletra were able to achieve and maintain an undetectable viral load for more than one year, according to a study presented at the 12th Annual Conference of the British HIV Association. Sustiva causes only modest changes to sleeping patterns and has no adverse effect on quality of life, according to a study in the May edition of HIV Medicine. Sleep studies showed only slight changes in sleep patterns, including a reduction in stage 2 sleep'thought to be linked with daytime alertness'and a lengthening of two dream-associated sleep stages. The study subjects did not report any changes in sleep quality or overall quality of life. Amazon Biotech filed paperwork with the FDA in April for a Phase I/II clinical trial of its experimental immune modulator AMZ 0026, which aims to prevent HIV infection from progressing to AIDS. The drug works to boost normal metabolic processes that support immune system function.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM